ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kingman Regional Medical Center Moves Toward Hepatitis C Eradication with MEDITECH Professional Services Support

Disease Management Clinic detects and cures over 60 patients through improved HCV testing

Mohave County in Arizona is among the top 5% of counties nationwide considered to be most susceptible to a hepatitis C outbreak. Leaders at Kingman Regional Medical Center (Kingman, AZ) knew that to address this issue and improve the health of their community, it was time for their Disease Management Clinic to establish a new initiative for hepatitis C virus (or HCV) treatment under the medical directorship of hepatologist, Dr. Richard Manch, MD, MS, FAASLD, FACP, FACG.

“While hepatitis C is easily treatable, symptoms often do not present until liver damage has occurred,” said Dr. Linda Williams, PharmD, Ambulatory Care Pharmacy Clinical Manager.

“Failing to detect the virus early can result in serious long-term health effects like cirrhosis, liver cancer, and liver transplant. That’s why it was important for us to establish our Hepatitis C Eradication program.”

The Disease Management Clinic is staffed by pharmacists, who partner with regional healthcare providers through a collaborative practice agreement to increase access to care and extend provider services.

The goal of KRMC’s initiative was to screen all patients over the age of 18 for HCV at least once in their lifetimes, as well as regularly test patients with high risk factors. The clinic consulted with MEDITECH Professional Services for guidance on how to extend the workflows in their MEDITECH Expanse EHR to more effectively screen, monitor, and treat patients.

“When we started out, our clinic hadn’t received an HCV test referral in over a year. But then we worked closely with MEDITECH Professional Services to incorporate hepatitis C screening protocols into our primary care documentation,” said Dr. Williams.

“Standard documentation was added to remind physicians to screen their patients and to document potential risk factors that may suggest a patient should have annual screenings. We also created standard order sets, referral options, a health protocol, and disease management clinic documentation for those patients who tested positive.”

Additionally, MEDITECH Professional Services worked with KRMC to create a pair of patient registries for monitoring patients in their program. “One registry tracks all patients who are positive for HCV. The other is used to track higher-risk patients, to make sure they are following through with annual screenings,” Dr. Williams said.

To track outcomes, MEDITECH Professional Services also collaborated with KRMC to personalize Business and Clinical Analytics dashboards around the needs of the program. “Interactive dashboards display the percent of patients screened, as well as results, age by decade, ethnicity, and other relevant patient details,” Dr. Williams added. “A Geographic Analysis dashboard helps to identify areas of potential outbreak, as well as areas where screening is light and more community outreach is needed.”

Since the program’s launch, KRMC’s lab has now screened an average of 164.5 patients per month, with a 6.5% positivity rate. “We now average 7.5 HCV referrals per month,” said Dr. Williams. “And as of February 2023, 64 patients have been cured of Hepatitis C through confirmatory labs drawn 12 weeks after finishing antiviral therapy.”

The success of KRMC’s program hinged on linkage to care through patient navigation and on making it affordable, as patients were often underinsured and the average cost for an 8-12 week HCV regimen runs between $20,000-$50,000. By securing over $400,000 in financial aid through foundation grants and commercial programs, the organization was able to keep the average co-pay between $0-$10, with the highest at $18.

Making the initiative accessible to more patients seems to be paying off. “By screening early for HCV antibodies, we’ve helped over 60 residents in our community increase their odds for longer, higher quality lives,” Dr. Williams said. “That’s an accomplishment we can all take pride in.”

Visit the MEDITECH Professional Services webpage for more information on their programs and customer successes.

About MEDITECH

MEDITECH empowers healthcare organizations to expand their vision of what’s possible with Expanse, the world’s most intuitive and interoperable EHR. Expanse lays the foundation for the next digital era, enabling care across delivery settings, designing cloud-based systems to drive better outcomes, and providing mobile, personalized solutions to improve efficiency for an overburdened workforce. Visit ehr.meditech.com, find MEDITECH Podcasts on your favorite platform, and follow us on Twitter, Facebook, and LinkedIn.

Kingman Regional Medical Center turns to @MEDITECH Professional Services to support #HepatitisC eradication; detecting and curing over 60 patients @KingmanAZEM #Expanse #HealthIT

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.